WASHINGTON — PhRMA has already spent $21 million on lobbying this year — a sum that puts it on course to smash its previous annual lobbying records.

The group, which represents dozens of major drug makers, spent nearly $6 million on advocacy in the third quarter of this year, according to lobbying disclosures released Monday, about $400,000 more than it spent in the same period last year. After an unprecedented first half of 2018, that total puts it just $4 million shy of a new record annual spend —and it hasn’t spent less than $4 million in a quarter since 2015.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Would you be interested in material showing a major Pharmaceutical company has “misrepresented” is nuclear isotope Sestamibi for decades and making hundreds of millions of dollars off those lies?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy